/Lists

Biotech Investors & VC Firms in North America

1593 firms in this list, with a median first check of $500K. 347 of them lead rounds. Generated from verified public data and updated continuously.

Mission Biocapital
San FranciscoPre-Seed–Series A$500K
21 people
AIF
New YorkSeed–Growth
39 people
Berkeley Frontier
BerkeleyPre-Seed–Late Stage
39 people
Cross Creek Advisors
Salt Lake CitySeries B–Late Stage
21 people
DRI Healthcare
Toronto$7.3M – $36.5M
44 people
Houston Angel Network
HoustonSeed–Growth
17 people
ACME Capital
San FranciscoPre-Seed–Growth
13 people
RiverVest Venture Partners
St. LouisSeed–Series C$500K – $3M
21 people
Two Bear Capital
WhitefishPre-Seed–Series B$3M – $10M
35 people
Decheng Capital
Menlo ParkSeed–Growth
14 people
A-Level Capital
BaltimorePre-Seed–Series B$40K – $100K
40 people
Avoro Capital Advisors
New YorkSeries A–Late Stage
22 people
JAZZ Venture Partners
San FranciscoSeed–Growth$100K – $20M
16 people
Asahi Kasei Corporate Venture Capital
Menlo ParkPre-Seed–Late Stage$200K – $5M
25 people
GOOSE Capital
HoustonPre-Seed–Series A
36 people
AIX Ventures
San FranciscoPre-Seed–Series A$1M – $5M
12 people
LIONHEART VENTURES
San FranciscoSeed–Growth
36 people
VantagePoint Capital Partners
Silicon ValleySeed–Late Stage$2M – $100M
18 people
Montage Capital
CampbellGrowth$500K – $5M
5 people
Compound
New YorkSeed–Series A$400K – $1.5M
12 people
BoxOne Ventures
MontréalPre-Seed–Series A$500K
8 people
TMV
New YorkPre-Seed–Series A$1.5M
14 people
LifeX Ventures
San FranciscoPre-Seed–Seed
17 people
T. Rowe Price
BaltimoreSeed–Series C
2 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.